Concepedia

Publication | Open Access

Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC

DOIFull Paper Access

46

Citations

46

References

2022

Year

Seung Yeon Oh, You Won Lee, Eun Ji Lee, Jae Hwan Kim, YoungJoon Park, Seong Gu Heo, Mi Ra Yu, Min Hee Hong, John O. DaSilva, Christopher Daly,
Clinical Cancer Research

Abstract

Altogether, REGN5093-M114 is a promising candidate to overcome the challenges facing functional MET pathway blockade.

References

YearCitations

Page 1